Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells

Cancer Immunology, Immunotherapy

Volumn 57, Issue 2, 2008, Pages 165-174

  Shinagawa, Naofumi ^a   Yamazaki, Koichi ^a   Tamura, Yasuaki ^b   Imai, Akihito ^b   Kikuchi, Eiki ^a   Yokouchi, Hiroshi ^a   Hommura, Fumihiro ^a   Oizumi, Satoshi ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cell; Gp96; Heat shock protein; Immunotherapy; Lung cancer

Indexed keywords

DENDRITIC CELL VACCINE; GLYCOPROTEIN GP 96; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; ENDOPLASMIC RETICULUM; ENDOSOME; FEMALE; IMMUNE RESPONSE; LEWIS CARCINOMA; LUNG CANCER; LYMPH NODE; LYSOSOME; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, LEWIS LUNG; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL;

EID: 36349011365     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0359-3     Document Type: Article

References (30)

1. Srivastava PK, DeLeo AB, Old LJ (1986) Tumor rejection antigens of chemically induced sarcoma of inbred mice. Proc Natl Acad Sci USA 83:3407-3411
2. Udono H, Srivastava PK (1993) Heat shock protein 70-associated peptides elicits specific cancer immunity. J Exp Med 178:1391-1396
3. b binding ovalubumin-derived peptides associated with the stress proteins HSP70 and GP96. Eur J Immunol 28:1016-1021
4. Srivastava PK (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20:395-425
5. Arnold D, Faath S, Rammensse H-G, Schild H (1995) Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182:885-889
6. Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585-1588
7. Yamazaki K, Nguyen T, Podack ER (1999) Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J Immunol 163:5178-5182
8. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278:117-120
9. Kojima T, Yamazaki K, Tamura Y, Ogura S, Tani K, Konishi J, Shinagawa N, Kinoshita I, Hizawa N, Yamaguchi E, Dosaka-Akita H, Nishimura M (2003) Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice. Hum Gene Ther 14:715-728
10. Binder RJ, Anderson KM, Basu S, Srivastava PK (2000) Heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol 165:6029-6035
11. Kuppner MC, Gastper R, Gelwer S, Nossner E, Ochhmann O (2001) The role of heat shock protein (hsp70) in dendritic cells maturation: HSP70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol 31:1602-1609
12. Singh-Jasuja H, Scherer HU, Hiif N, Arnold-Schild D, Rammensee HG, Toes REM, Schild H (2000) The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30:2211-2215
13. + T cells in vivo. Proc Natl Acad Sci USA 91:3077-3081
14. Ueda G, Tamura Y, Hirai I, Kamiguchi K, Ichimiya S, Torigoe T, Hiratsuka H, Sunakawa H, Sato N (2004) Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. Cancer Sci 95:248-253
15. Moore MW, Carbone FR, Bevan MJ (1998) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-785
16. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702
17. Srivastava PK (1997) Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods 12:165-171
18. Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj J, Podack ER (1999) Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2. Cancer Res 59:4642-4650
19. Singh-Jasuja H, Toes RE, Spee P, Munz C, Hilf N, Schoenberger SP, Ricciardi-Castagnoli P, Neefjes J, Rammensee HG, Arnold-Schild D, Schild H (2000) Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 191:1965-1974
20. Zeng Y, Feng H, Graner MW, Katsanis E (2003) Tumor-derived chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood 101:4485-4491
21. Graner MW, Zeng Y, Feng H, Katsanis E (2003) Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol Immunother 51:226-234
22. Strbo N, Oizumi S, Sotosek-Tokmadzic V, Podack ER (2003) Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18:381-390
23. Lu Z, Yuan L, Zhou X, Sotomayor E, Levitsky HI, Pardoll DM (2000) CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes. J Exp Med 191:541-550
24. Chandarwarker RY, Wagh MS, Srivastava PK (1999) The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 189:1437-1442
25. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313
26. Delneste Y, Magistrelli G, Gauchat JF, Haeuw JF, Aubry JP, Nakamura K, Kawakami-Honda N, Goetsch L, Sawamura T, Bonnefoy JY, Jeannin P (2002) Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353-362
27. Berwin B, Rosser MFN, Brinker KG, Nicchitta CV (2002) Transfer of GRP94 (Gp96)-associated peptides onto endosomal MHC class I molecules. Traffic 3:358-366
28. Mazzaferro V, Coppa J, Carrabba MG, Rivoltini L, Schiavo M, Regalia E, Mariani L, Camerini T, Marchiano A, Andreola S, Camerini R, Corsi M, Lewis JJ, Srivastava PK, Parmiani G (2003) Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res 9:3235-3245
29. Parmiani G, Testori A, Maio M, Castelli C, Rivoltini L, Pilla L, Belli F, Mazzaferro V, Coppa J, Patuzzo R, Sertoli MR, Hoos A, Srivastava PK, Santinami M (2004) Heat shock proteins and their use as anticancer vaccines. Clin Cancer Res 10:8142-8146
30. Qian J, Wang S, Yang J, Xie J, Lin P, Freeman III ME, Yi Q (2005) Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96. Clin Cancer Res 11:8808-8815